Indo Us Bio-Tech Peer Comparison
NSE: INDOUS | BSE: 541304
₹80.91
₹0.12
(0.15%)
As on 28-Aug-2026IST
Market cap
₹165 Cr
Revenue (TTM)
₹113 Cr
P/E Ratio
14.4
P/B Ratio
1.7
Div. Yield
0 %
Edit
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
165 | 4,053 | 1,819 | 1,791 | 1,459 |
Revenue (₹ Cr) |
113 | 1,279 | 2,002 | 1,869 | 1,478 |
Net Profit (₹ Cr) |
11.46 | 248.50 | 60.82 | 78.36 | 125.12 |
Net Margin (%) |
10.15 | 19.09 | 3.03 | 4.13 | 8.40 |
RoE (%) |
12.79 | 14.05 | 17.61 | 14.22 | 15.66 |
Price to Earnings |
14.44 | 16.24 | 17.61 | 23.40 | 11.66 |
Price-To-Book |
1.73 | 1.99 | 1.32 | 2.88 | 1.68 |
Income Statement (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Operating Revenue
|
103.84 | 1,204.97 | 2,001.65 | 1,348.19 | 1,495.26 |
|
Total Income
|
104.02 | 1,251.33 | 2,004.03 | 1,374.20 | 1,503.94 |
|
Total Expenditure
|
84.90 | 914.09 | 1,838.00 | 1,268.59 | 1,354.18 |
|
EBITDA
|
18.94 | 290.88 | 163.65 | 79.60 | 141.07 |
|
Depreciation
|
1.10 | 39.83 | 7.03 | 3.11 | 3.61 |
|
EBIT
|
17.84 | 251.05 | 156.63 | 76.49 | 137.46 |
|
Interest
|
1.49 | 0.19 | 78.78 | 17.76 | 9.77 |
|
Other Income
|
0.18 | 46.36 | 2.38 | 26.00 | 8.68 |
|
Exceptional Items
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
16.53 | 297.22 | 80.23 | 84.74 | 136.37 |
|
Provision for Tax
|
0.26 | 14.94 | 19.41 | 23.51 | 33.49 |
|
Profit after Tax
|
16.27 | 282.28 | 60.82 | 61.24 | 102.88 |
Liabilities (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
78.52 | 1,499.16 | 379.18 | 425.64 | 733.27 |
|
Minority Interest
|
-- | 4.30 | -- | 2.66 | -- |
|
Non-Current Liabilities
|
2.29 | 99.07 | 5.33 | 3.85 | 63.03 |
|
Current Liabilities
|
16.34 | 1,093.44 | 1,164.52 | 478.61 | 171.48 |
|
Total Liabilities
|
97.84 | 2,695.97 | 1,549.03 | 910.76 | 967.78 |
Assets (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
10.42 | 645.66 | 97.99 | 50.97 | 162.37 |
|
Current Assets
|
86.73 | 2,050.15 | 1,451.04 | 859.79 | 805.41 |
|
Total Assets
|
97.84 | 2,695.97 | 1,549.03 | 910.76 | 967.78 |
|
Total Debt*
|
14.84 | 0.00 | 784.06 | 364.16 | 123.16 |
|
Net Current Assets
|
70.39 | 956.71 | 286.52 | 381.18 | 633.93 |
|
Contingent Liabilities
|
0.98 | 223.09 | 150.12 | 2.48 | -- |
Cashflow (₹ Cr)
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1.42 | 196.91 | 94.96 | 62.34 | 72.68 |
|
Cash Flow from Investing Activities
|
-0.79 | -182.53 | -0.04 | -7.73 | -11.13 |
|
Cash from Financing Activities
|
-1.48 | -17.86 | -93.30 | -11.74 | -61.64 |
|
Net Cash Inflow / Outflow
|
-0.85 | -3.48 | 1.62 | 42.87 | -0.08 |
Ratios
Profitability Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
ROCE (%)
|
21.15 | 21.77 | 14.12 | 13.58 | 18.43 |
|
ROE (%)
|
23.03 | 20.67 | 17.61 | 17.05 | 15.98 |
|
ROA (%)
|
17.98 | 11.77 | 4.29 | 7.29 | 10.49 |
|
EBIT Margin (%)
|
18.41 | 27.99 | 8.29 | 7.83 | 10.02 |
|
Net Margin (%)
|
15.64 | 22.56 | 3.03 | 4.46 | 6.84 |
|
Cash Profit Margin (%)
|
16.72 | 26.73 | 3.39 | 4.77 | 7.12 |
Growth Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
42.56 | 4.93 | 29.18 | 2.72 | 10.30 |
|
EBIT Growth (%)
|
71.86 | -3.38 | 48.83 | 0.84 | -12.66 |
|
Net Profit Growth (%)
|
97.15 | -5.87 | 100.04 | 0.85 | -11.03 |
|
EPS Growth (%)
|
97.15 | -5.83 | 98.93 | 1.36 | -7.44 |
|
Book Value Growth (%)
|
25.13 | 21.62 | 21.74 | 18.54 | 3.04 |
Valuation Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Price / Earnings
|
18.15 | 23.10 | 0.00 | 8.68 | 15.02 |
|
Price / Book Value
|
3.76 | 4.34 | 0.00 | 4.05 | 2.36 |
|
Dividend Yield (%)
|
0.17 | 0.40 | -- | 0.00 | 0.80 |
|
EV/EBITDA
|
16.21 | 19.21 | 5.10 | 17.89 | 10.76 |
|
Market Cap (₹ Cr)
|
295.26 | 6,499.01 | 0.00 | 1,578.33 | 1,545.05 |
Solvency Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.19 | 0.00 | 2.07 | 0.93 | 0.19 |
|
Short term debt to equity ratio
|
0.13 | -- | 2.06 | 0.85 | 0.08 |
|
Current Ratio
|
5.31 | 1.88 | 1.25 | 1.80 | 4.70 |
|
Quick Ratio
|
0.98 | 0.93 | 0.45 | 1.15 | 2.17 |
|
Interest Coverage
|
12.09 | 1,565.31 | 2.02 | 5.77 | 14.95 |
Operating Efficiency Ratios
| Indo Us Bio-Tech | Kaveri Seed | Amir Chand Jagdish Kumar (Exports) | GRM Overseas | Chaman Lal Setia | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
14.45 | 7.67 | 22.51 | 35.61 | 15.28 |
|
Asset Turnover
|
1.15 | 0.50 | 1.41 | 1.60 | 1.52 |
|
Receivable days
|
59.84 | 30.94 | 70.57 | 130.21 | 52.25 |
|
Inventory Days
|
215.16 | 268.26 | 157.08 | 71.95 | 113.90 |
|
Payable days
|
597.69 | 279.62 | 21.63 | 9.51 | 3.06 |
|
Cash Conversion Cycle
|
-322.69 | 19.58 | 206.02 | 192.66 | 163.09 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
